Oncofertility Resources at NCI-Designated Comprehensive Cancer Centers

被引:34
|
作者
Clayman, Marla L. [1 ]
Harper, Maya M. [1 ]
Quinn, Gwendolyn P. [2 ]
Reinecke, Joyce [3 ]
Shah, Shivani [4 ]
机构
[1] Northwestren Univ Chicago, Feinberg Sch Med, Div Gen Internal Med, Chicago, IL USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[3] Fertile Hope, LIVESTRONG, Austin, TX USA
[4] Adventist Hlth Partners, Hinsdale, IL USA
关键词
NEWLY-DIAGNOSED CANCER; FERTILITY PRESERVATION; COMPETING DEMANDS; PRIMARY-CARE; REPRODUCTIVE HEALTH; CHALLENGES; SURVIVORS; BARRIERS; MODEL;
D O I
10.6004/jnccn.2013.0177
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
NCI-designated comprehensive cancer centers (CCCs) set the standard for providing exemplary patient care. Quality cancer care includes discussions about fertility and referrals to fertility specialists for patients at risk for sterility. This study sought to determine what fertility preservation (FP) resources are available in CCCs and how well those are integrated into patient care. Leaders at each CCC received a letter requesting a short telephone interview with individuals who could provide information about the institution's FP resources. A semi-structured interview guide was used and responses were audio-recorded. Data were analyzed using content and thematic analysis. Interviews were conducted with 30 of the 39 CCCs that see adult patients (77%). The remaining institutions included 4 nonresponders, 3 that referred the interviewers to childhood cancer survivorship clinics, 1 that refused, and 1 that could not identify any FP resources. Participants were primarily affiliated with reproductive endocrinology (n=15) or hematology/oncology divisions (n=10). Institutional policies regarding consistent provision of FP information were rare (n=4), although most sites (n=20) either had some services on-site or had referral programs (n=8). However, only 13 had some experimental services, such as ovarian tissue cryopreservation. Respondents reported barriers to provision of FP, including oncologists' identification of patients at risk, low referral rates, and perceptions of patient prognosis. Only 8 (27%) sites had staff with time dedicated to FP. CCCs vary widely in implementing FP-recommended practice to their patients. CCCs are positioned to provide exemplary oncofertility care, but most need to better integrate FP information and referral into practice.
引用
收藏
页码:1504 / 1509
页数:6
相关论文
共 50 条
  • [21] Accessibility and barriers to oncology appointments at 40 NCI-designated cancer centers.
    Hamlyn, Geoffrey
    Hutchins, Kathryn
    Johnston, Abby
    Thomas, Rishonda
    Tian, James
    Kamal, Arif
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [22] Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers
    Angelin Tresa Mathew
    Bhav Jain
    Edward Christopher Dee
    Jordan Johnson
    Fumiko Chino
    Annals of Surgical Oncology, 2022, 29 : 3381 - 3383
  • [23] Blood cancer survivorship in NCI-Designated Cancer Centers: a study of services, gaps, and access barriers
    Reinhart, Crystal A.
    Sae-Hau, Maria
    Lee, Carol A.
    Weiss, Elisa S.
    JOURNAL OF CANCER SURVIVORSHIP, 2020, 14 (01) : 43 - 47
  • [24] Mapping global oncology priorities: A survey of the directors of the NCI-designated cancer centers.
    Prakash, Laura
    Estes, Taylor
    Garton, Elise M.
    Eldridge, Linsey
    Cira, Mishka K.
    Duncan, Kalina
    Gopal, Satish
    He, Min
    Ciolino, Henry
    Loehrer, Patrick J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] Ernest Hawk discusses the NCI-designated cancer centers' joint statement on the HPV vaccine
    Hawk, Ernest T.
    ONCOLOGY-NEW YORK, 2016, 30 (07): : 599 - 600
  • [26] CLINICIAN-TO-CLINICIAN CONNECTEDNESS AND ACCESS TO GASTRIC CANCER SURGERY AT NCI-DESIGNATED CANCER CENTERS
    McDermott, James
    Aminpour, Nathan
    Phan, Vy
    Wang, Haijun
    Valentin, Michelle
    Mishra, Ankit
    Delia, Derek
    Noel, Marcus
    Al-Refaie, Waddah
    GASTROENTEROLOGY, 2023, 164 (06) : S1517 - S1517
  • [27] Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers
    Mathew, Angelin Tresa
    Jain, Bhav
    Dee, Edward Christopher
    Johnson, Jordan
    Chino, Fumiko
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (06) : 3381 - 3383
  • [28] What are NCI-designated cancer centers using for breast cancer HER2 testing?
    Siziopikou, Kalliopi P.
    Weldon, Christine B.
    Trosman, Julia R.
    Gradishar, William John
    Schink, Julian C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Blood cancer survivorship in NCI-Designated Cancer Centers: a study of services, gaps, and access barriers
    Crystal A. Reinhart
    Maria Sae-Hau
    Carol A. Lee
    Elisa S. Weiss
    Journal of Cancer Survivorship, 2020, 14 : 43 - 47
  • [30] Identifying patients for clinical trials: Evaluation of NCI-designated community cancer centers.
    Mackay, Christine B.
    Hepler, Kerry
    Erickson, Kirsten D.
    Daley, Christine
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)